Vangelis Vergetis

Vangelis has been working in the intersection of healthcare, technology, and data science for ~20 years. He is currently a co-founder and the CEO of Epikast, Inc., a company that partners with biopharmaceutical companies as they engage their most important stakeholders: patients, physicians, and other caregivers. He started his career as a consultant at McKinsey and at Hakluyt, where he spent twelve years advising biopharmaceutical executives on several topics - particularly in launching drugs across disease areas, and in designing and implementing their commercial models and infrastructure. Immediately prior to Epikast, Vangelis was the co-founder and CEO of Intelligencia, a software company that utilizes AI to assess and reduce the risk of clinical trials. He currently serves as a board advisor to the company. He was a founding board member and member of the executive committee at the Alliance for AI in Healthcare (AAIH), and a former member of the advisory board for Cornell's Bowers College of Computing & Information Science (CIS). He also serves as a member of the External Review Committee, for the Technology Development Fund of Memorial Sloan Kettering Cancer Center. Vangelis holds a PhD in Electrical Engineering from the University of Pennsylvania, and a BS in Computer Science from Cornell University.